Ide 2021.
Study characteristics | |||
Patient Sampling |
Purpose: diagnosis of SARS‐CoV‐2 infection (mild COVID‐19 disease) ‐ to evaluate the SARS‐CoV‐2‐positive ratio among mildly ill patients in Tokyo, Japan, their characteristics, the Ministry of Health, Labour and Welfare criteria, and to identify better criteria Design: cross‐sectional cohort study, retrospective data collection Recruitment: patients who underwent SARS‐CoV‐2 PCR testing at the National Center for Global Health and Medicine in Tokyo (= outpatient screening centre) Sample size: n = 277 (25 cases) Inclusion criteria: those who met ≥ 1 of the following criteria were eligible: patients who have fever or symptoms (e.g. respiratory, fatigue, headache, myalgia); patients who had exposure to COVID‐19 patient; patients who did not meet 1) or 2) but referred by another physician due to possible exposure to COVID‐19 patient or travel history. Exclusion criteria: patients who were non‐ambulatory upon presentation (referred to the infectious disease clinic for further evaluation) |
||
Patient characteristics and setting |
Facility cases: RT‐PCR‐positive for SARS‐COV‐2 Facility controls: RT‐PCR‐negative for SARS‐COV‐2 Country: Japan Dates: 09 March 2020‐29 March 2020 Symptoms and severity: mild to moderate severity Demographics: age: controls median 38.9 years, cases median 44.1 years M%/F%: cases 88.0/12.0, controls 52.0/48.0 Exposure history: exposure to case: cases 52%, controls 7%; travel: cases 72%, controls 20% |
||
Index tests |
|
||
Target condition and reference standard(s) |
|
||
Flow and timing | Timing not specified | ||
Comparative | |||
Notes | Funding: grant for International Health Research from the Ministry of Health Labor and Welfare of Japan (grant no. 20A2003D) | ||
Methodological quality | |||
Item | Authors' judgement | Risk of bias | Applicability concerns |
DOMAIN 1: Patient Selection | |||
Was a consecutive or random sample of patients enrolled? | Unclear | ||
Was a case‐control design avoided? | Yes | ||
Did the study avoid inappropriate exclusions? | No | ||
Did the study avoid inappropriate inclusions? | Yes | ||
Could the selection of patients have introduced bias? | High risk | ||
Are there concerns that the included patients and setting do not match the review question? | Low concern | ||
DOMAIN 2: Index Test (All tests) | |||
Were the index test results interpreted without knowledge of the results of the reference standard? | Unclear | ||
If a threshold was used, was it pre‐specified? | No | ||
Could the conduct or interpretation of the index test have introduced bias? | High risk | ||
Are there concerns that the index test, its conduct, or interpretation differ from the review question? | Low concern | ||
DOMAIN 3: Reference Standard | |||
Is the reference standards likely to correctly classify the target condition? | Yes | ||
Were the reference standard results interpreted without knowledge of the results of the index tests? | Unclear | ||
Could the reference standard, its conduct, or its interpretation have introduced bias? | Low risk | ||
Are there concerns that the target condition as defined by the reference standard does not match the question? | Low concern | ||
DOMAIN 4: Flow and Timing | |||
Was there an appropriate interval between index test and reference standard? | Unclear | ||
Did all patients receive the same reference standard? | Yes | ||
Were all patients included in the analysis? | Yes | ||
Could the patient flow have introduced bias? | Unclear risk |